Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC).

Authors: Daniel Bsteh, Jonathan Buckley, Scott Mitchell, Dejerianne Ostrow, Jean-Hugues Parmentier, Samin Jahan, Seth Sadis, Jeff Smith, Jingwei NI, Xinzhan Peng, David James McConkey, Tanya B. Dorff, Seth P. Lerner, Ana Aparicio, Brian Francis Chapin, Vinay Duddalwar, Timothy Junius Triche, Amir Goldkorn

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17111

Source: Full article

---

Abstract

e17111